TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
CERS

Cerus Corporation

Healthcare · Medical Devices

2.60$ +0.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow CERS
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-109.1% -149.4% -144.0% -119.9% -51.3% -87.7% -45.5% -25.9% -15.8% -27.6% 6.3% 5.5%
3.9% 5.0% 4.9% 4.2% 2.4% 3.2% 3.4% 2.4% 1.8% 1.7% 1.0% 0.9%
14.1% 19.7% 21.7% 21.5% 17.1% 17.8% 19.6% 18.0% 15.1% 13.0% 12.7% 11.1%
-6.6% 10.8% 22.9% 14.5% 19.1% 18.4% 20.2% 20.4% 16.4% – – –
-0.2% 8.0% -2.6% -8.3% 21.7% -16.5% -4.6% -7.2% -9.9% -20.5% 2.9% -3.3%
5.8% 2.1% 1.5% 0.8% 1.9% 12.0% 1.8% 0.7% 1.2% 2.9% 1.6% 1.4%
-9.2% 4.1% -53.6% 1.0% -72.0% 37.8% -53.9% 9.7% 5.2% 5.5% -4.5% -3.9%
0.0% 0.0% 0.0% 0.0% – – – – 2.6% 6.7% – –
82.4% 257.3% 67.7% 74.9% 152.5% 40.4% 96.0% 10.0% -0.1% -0.1% – –
17.5% 28.9% -1.7% 23.8% -0.2% 17.9% 3.8% 16.2% 0.1% 6.3% 2.4% -0.2%
99.9% 286.2% 66.1% 98.7% 152.3% 58.3% 99.9% 26.2% 2.6% 6.8% 2.8% 2.4%
-18.4% 140.9% -131.5% -20.2% 29.0% 7.8% 1.6% 9.3% -8.4% -15.3% 4.4% 3.9%
-114.8% -151.5% -145.5% -120.7% -53.2% -99.7% -47.2% -26.6% -17.0% -30.5% 4.7% 4.1%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?